但这种垄断格局，即将被打破，多款在研新药正从作用机制到给药方式，向Vosoritide发起挑战。Ascendis的TransCon-CNP通过包裹技术延长了药物作用时间，实现了周剂给药，目前正处于FDA审批阶段；而BridgeBio的口服药Infigratinib，则从作用机制到用药体验实现全面突破。
Opens in a new window
。搜狗输入法下载对此有专业解读
Burger King is testing AI-powered headsets that can recite recipes, alert managers when inventories are low and even track how friendly employees are to customers.
connection, to the computer, which then responded with a command such as